Stockreport

Here's How Sanofi Hopes to Avoid the Patent Cliff [The Motley Fool]

BIOVERATIV INC COMMON  (BIVV) 
Last bioverativ inc common earnings: 2/13 04:15 pm Check Earnings Report
PDF Acquisitions may help the company navigate risks. This week, Sanofi ( NYSE:SNY )   announced  that it's buying hemophilia drug developer Bioverativ ( [Read more]